FDA approves InnoPharma ANDA for acetylcysteine injection
The acetylcysteine injection, which is a generic equivalent of Cumberland Pharmaceuticals’ Acetadote injection, is indicated as an antidote to prevent or lessen hepatic injury that occurs following the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.